Below are the top 10 fastest-growing Biotechnology stocks, UPDATED TODAY before 4:30 AM ET, based on the average long-term earnings growth rate estimated by Wall Street analysts. Two Chinese companies (SHP, WX) are on the list.United Therapeutics Corporation (NASDAQ:UTHR) is the 1st fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 70.7%. This number is based on the average estimate of 7 brokerage analysts.
Genzyme Corporation (NASDAQ:GENZ) is the 2nd fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 25.1%. This number is based on the average estimate of 9 brokerage analysts.
Celgene Corporation (NASDAQ:CELG) is the 3rd fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 24.9%. This number is based on the average estimate of 10 brokerage analysts.
EXACT Sciences Corporation (NASDAQ:EXAS) is the 4th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 23.3%. This number is based on the average estimate of 3 brokerage analysts.
ShangPharma Corp (ADR) (NYSE:SHP) is the 5th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 21.2%. This number is based on the average estimate of 4 brokerage analysts.
WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) is the 6th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 19.2%. This number is based on the average estimate of 5 brokerage analysts.
PAREXEL International Corporation (NASDAQ:PRXL) is the 7th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 17.5%. This number is based on the average estimate of 7 brokerage analysts.
Meridian Bioscience, Inc. (NASDAQ:VIVO) is the 8th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 15.8%. This number is based on the average estimate of 5 brokerage analysts.
ViroPharma Incorporated (NASDAQ:VPHM) is the 9th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 15.7%. This number is based on the average estimate of 3 brokerage analysts.
Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) is the 10th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 15.2%. This number is based on the average estimate of 9 brokerage analysts.
No comments:
Post a Comment